Research Nova Scotia is contributing $600,000 in rapid response match funding to Dr. David Kelvin of Dalhousie University who is looking for biomarkers that indicate the severity of the illness caused by the novel coronavirus.
Kelvin and his international research colleagues are looking for a way to quickly identify the severity of the virus in those who test positive for COVID-19. RNS is joining the Canadian Institutes of Health Research’s COVID-19 funding initiative, which has committed $1 million to the project, and the Dalhousie Medical Research Foundation, which has allotted $250,000.